🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Evercore ISI cuts R1 RCM to In Line, raises target to $16

Published 28/02/2024, 08:26 am
© Reuters.
RCM
-

On Tuesday, Evercore ISI adjusted its stance on R1 RCM Inc (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services for healthcare providers, moving its rating from Outperform to In Line. The firm also increased its price target for the company's shares to $16.00, up from the previous $12.00.

The downgrade comes despite a positive view of the company's performance, with R1 RCM having an "exciting week" and a strong year in 2023. The analyst at Evercore ISI acknowledged the detailed 2024 guidance provided by R1 RCM's management, which includes various factors such as customer attrition, acquisition ramp, and synergies. The guidance was seen as reasonable and commendable for its level of detail.

In light of the updated guidance, Evercore ISI has revised its estimates for R1 RCM. The firm has removed the Sutter Phase 2 from its estimates until further clarity is provided regarding the go-forward agreement. The analyst anticipates R1 RCM to continue as a high single-digit to low double-digit organic grower, with potential for growth in EBITDA in the teens as the company benefits from increased profitability at customers and additional synergies.

Despite the positive growth outlook, Evercore ISI has decided to adopt a more neutral position, citing the recent increase in valuation. The firm believes that the current share price now reflects a balanced risk/reward profile for investors, prompting the shift to an In Line rating.

The new price target of $16 is based on an 11x multiple of the projected 2025 EBITDA, as per the analyst's comments. This adjustment reflects a recognition of the company's future earnings potential while also accounting for the current market valuation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.